Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
GSK
Biotech
GSK aiming to ‘balance West and East’ since Hansoh deal success
GSK has been operating a strategy of “balancing the West and the East” since the Big Pharma’s collaboration with Hansoh, according to an executive.
James Waldron
Sep 23, 2026 5:00am
GSK doubles down on Chimagen with $750M multiple myeloma wager
Sep 15, 2026 7:15am
GSK’s ADC lays down marker for lung cancer scrap with Merck
Sep 12, 2026 7:00pm
GSK pens $1.3B Hutchmed deal for KRAS-EGFR cancer asset
Sep 3, 2026 7:45am
GSK plans phase 3 after mRNA flu vaccine beats standard shots
Sep 1, 2026 5:43am
GSK, AI biotech Relation pen $110M biological datasets pact
Jul 30, 2026 9:46am
